Improved oral nutraceutical-based intervention for the management of obesity: pterostilbene-loaded chitosan
Lamia A Heikal1, Amal H El-Kamel1, Radwa A Mehanna2,3
1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, El-Khartoum square, Azarita, Postal code: 21521, Alexandria, Egypt.
Abstract:
Aim: To formulate and assess the oral anti-obesity effect of polymeric-based pterostilbene (PS)-loaded nanoparticles. Methods: Pterostilbene-hydroxypropyl β-cyclodextrin inclusion complex loaded in chitosan nanoparticles (PS/HPβCD-NPs) were prepared and characterized in vitro. Cytotoxicity, pharmacokinetics and anti-obesity effects were assessed on Caco-2 cell line and high-fat-diet-induced obesity rat model, respectively. In vivo assessment included histological examination, protein and gene expression of obesity biomarkers in adipose tissues. Results: Safe PS/HPβCD-NPs were successfully prepared with improved bioavailability compared with free PS. PS/HPβCD-NPs showed an improved anti-obesity effect, as supported by histological examination, lipid profile, UCP1 gene expression and protein expression of SIRT1, COX2, IL-6 and leptin. Conclusion: Orally administered PS nanoparticles represent a new and promising anti-obesity strategy owing to the sustainable weight loss and minimal side effects; this may be of great socio-economic impact.
Related Concept Videos
01:26Atherosclerosis III: Management
01:24Obesity